IP Library Granted Patent US 12,544,381
Granted Patent B2
US 12,544,381 · App. 19/171,214 · Granted Feb 10, 2026

Topical formulation for JAK inhibitor

Inventors: Bhavnish Parikh (Avondale, PA); Bhavesh Shah (San Antonio, TX); Krishnaswamy Yeleswaram (Landenberg, PA)
Assignees: Incyte Corporation; Incyte Holdings Corporation
A61K31/519A61K9/0014A61K9/06A61K9/107A61K47/06A61K47/10A61K47/14A61K47/24A61K47/26A61K47/36A61P17/00A61P17/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,381
App. No.
19/171,214
Granted
Feb 10, 2026
Kind
B2
Abstract

This invention relates to pharmaceutical formulations for topical skin application comprising (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile, or a pharmaceutically acceptable salt thereof, and use in the treatment of skin disorders.

Claims (227)

1 . A pharmaceutical formulation for topical skin application, wherein the formulation is an oil-in-water emulsion, the formulation comprising:

from 35% to 65% by weight of the formulation of water;

from 10% to 40% by weight of the formulation of a mixture of petrolatum, C 16-18 fatty alcohols, mineral oil, a triglyceride, and a silicone oil;

from 2% to 6% by weight of the formulation of a mixture of a glyceryl fatty ester and a sorbitan fatty ester;

from 0.05% to 5% by weight of the formulation of a polysaccharide;

from 10% to 35% by weight of the formulation of a mixture of an alkylene glycol and a polyalkylene glycol; and

1.5% of by weight of the formulation on a free base basis of 1:1 (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphoric acid salt;

wherein the oil-in-water emulsion has a pH of not greater than 3.6.

2 . The formulation according to claim 1 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol;

wherein the pH ranges from 2.9 to 3.6.

3 . The formulation according to claim 1 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate SE;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol 200.

4 . The formulation according to claim 2 , further comprising:

a chelating agent component; and

from 0.05% to 3% by weight of the formulation of an antimicrobial preservative component.

5 . The formulation of claim 3 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol.

6 . The formulation according to claim 1 , wherein:

the water comprises from 40% to 60% by weight of the formulation;

the mixture of petrolatum, C 16-18 fatty alcohols, mineral oil, a triglyceride, and a silicone oil comprises from 17% to 27% by weight of the formulation;

the mixture of a glyceryl fatty ester and a sorbitan fatty ester comprises from 3% to 5% by weight of the formulation;

the polysaccharide comprises from 0.1% to 2% by weight of the formulation; and

the mixture of an alkylene glycol and a polyalkylene glycol comprises from 15% to 30% by weight of the formulation.

7 . The formulation according to claim 6 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol.

8 . The formulation according to claim 6 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate SE;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol 200.

9 . The formulation according to claim 7 , further comprising:

a chelating agent component; and

from 0.05% to 3% by weight of the formulation of an antimicrobial preservative component.

10 . The formulation of claim 8 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol.

11 . The formulation according to claim 1 , wherein:

the water comprises from 45% to 55% by weight of the formulation;

the mixture of petrolatum, C 16-18 fatty alcohols, mineral oil, a triglyceride, and a silicone oil comprises from 20% to 27% by weight of the formulation;

the mixture of a glyceryl fatty ester and a sorbitan fatty ester comprises from 3% to 5% by weight of the formulation;

the polysaccharide comprises from 0.3 to 0.5% by weight of the formulation; and

the mixture of an alkylene glycol and a polyalkylene glycol comprises from 20% to 25% by weight of the formulation.

12 . The formulation according to claim 11 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol.

13 . The formulation according to claim 11 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate SE;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol 200.

14 . The formulation according to claim 12 , further comprising:

a chelating agent component; and

from 0.05% to 3% by weight of the formulation of an antimicrobial preservative component.

15 . The formulation of claim 13 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol.

16 . A pharmaceutical formulation for topical skin application, wherein the formulation is an oil-in-water emulsion, the formulation comprising:

45% to 55% by weight of the formulation of water;

7% by weight of the formulation of a petrolatum;

4.75% by weight of the formulation of C 16-18 fatty alcohols;

4% by weight of the formulation of a mineral oil;

5% by weight of the formulation of a triglyceride;

1% by weight of the formulation of a silicone oil;

3% by weight of the formulation of a glyceryl fatty ester;

1.25% by weight of the formulation of a sorbitan fatty ester;

0.4% by weight of the formulation of a polysaccharide;

15% by weight of the formulation of an alkylene glycol;

7% by weight of the formulation of a polyalkylene glycol; and

1.5% of by weight of the formulation on a free base basis of 1:1 (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphoric acid salt;

wherein the oil-in-water emulsion has a pH of not greater than 3.6.

17 . The formulation of claim 16 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol;

wherein the pH ranges from 2.9 to 3.6.

18 . A pharmaceutical formulation for topical skin application, wherein the formulation is an oil-in-water emulsion, the formulation comprising:

45% to 55% by weight of the formulation of water;

7% by weight of the formulation of white petrolatum;

3% by weight of the formulation of cetyl alcohol;

1.75% by weight of the formulation of stearyl alcohol;

4% by weight of the formulation of light mineral oil;

5% by weight of the formulation of medium chain triglycerides;

1% by weight of the formulation of dimethicone;

3% by weight of the formulation of glyceryl stearate;

1.25% by weight of the formulation of polysorbate 20;

0.4% by weight of the formulation of xanthan gum;

15% by weight of the formulation of propylene glycol;

7% by weight of the formulation of polyethylene glycol; and

1.5% of by weight of the formulation on a free base basis of 1:1 (R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile phosphoric acid salt;

wherein the oil-in-water emulsion has a pH of not greater than 3.6.

19 . The formulation of claim 18 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol;

wherein the pH ranges from 2.9 to 3.6.

20 . The formulation of claim 18 , wherein the pH ranges from 2.9 to 3.6.

21 . The formulation according to claim 1 , wherein:

the water comprises from 40% to 60% by weight of the formulation;

the mixture of petrolatum, C 16-18 fatty alcohols, mineral oil, a triglyceride, and a silicone oil comprises from 17% to 27% by weight of the formulation;

the mixture of a glyceryl fatty ester and a sorbitan fatty ester comprises from 3% to 5% by weight of the formulation;

the polysaccharide comprises from 0.1% to 2% by weight of the formulation; and

the mixture of an alkylene glycol and a polyalkylene glycol comprises from 15% to 30% by weight of the formulation;

wherein the pH ranges from 2.9 to 3.6.

22 . The formulation according to claim 21 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol.

23 . The formulation according to claim 21 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate SE;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol 200.

24 . The formulation according to claim 22 , further comprising:

a chelating agent component; and

from 0.05% to 3% by weight of the formulation of an antimicrobial preservative component.

25 . The formulation of claim 24 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol.

26 . The formulation according to claim 1 , wherein:

the water comprises from 45% to 55% by weight of the formulation;

the mixture of petrolatum, C 16-18 fatty alcohols, mineral oil, a triglyceride, and a silicone oil comprises from 20% to 27% by weight of the formulation;

the mixture of a glyceryl fatty ester and a sorbitan fatty ester comprises from 3% to 5% by weight of the formulation;

the polysaccharide comprises from 0.3 to 0.5% by weight of the formulation; and

the mixture of an alkylene glycol and a polyalkylene glycol comprises from 20% to 25% by weight of the formulation;

wherein the pH ranges from 2.9 to 3.6.

27 . The formulation according to claim 26 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol.

28 . The formulation according to claim 26 , wherein:

the petroleum is white petrolatum;

the C 16-18 fatty alcohols are a mixture of cetyl alcohol and stearyl alcohol;

the mineral oil is light mineral oil;

the triglyceride is medium chain triglycerides;

the silicone oil is dimethicone;

the glyceryl fatty ester is glyceryl stearate SE;

the sorbitan fatty ester is polysorbate 20;

the polysaccharide is xanthan gum;

the alkylene glycol is propylene glycol; and

the polyalkylene glycol is polyethylene glycol 200.

29 . The formulation according to claim 27 , further comprising:

a chelating agent component; and

from 0.05% to 3% by weight of the formulation of an antimicrobial preservative component.

30 . The formulation of claim 29 , further comprising:

0.1% by weight of the formulation of methyl paraben;

0.05% by weight of the formulation of propyl paraben;

0.05% by weight of the formulation of edetate disodium; and

0.5% by weight of the formulation of phenoxyethanol.

Assignments (2)
ASSIGNOR'S INTEREST IN PART Recorded Apr 5, 2025
From: INCYTE CORPORATION
To: INCYTE HOLDINGS CORPORATION
Reel/Frame 070746/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2025
From: PARIKH, BHAVNISH; YELESWARAM, KRISHNASWAMY; SHAH, BHAVESH
To: INCYTE CORPORATION
Reel/Frame 070747/0152 →
Continuity (8)
Continuation 17541439 · Dec 3, 2021
Continuation 16948408 · Sep 17, 2020
Continuation 16947735 · Aug 14, 2020
Division 16566625 · Sep 10, 2019
Continuation 14714820 · May 18, 2015
Continuation 13112370 · May 20, 2011
Provisional Application 61347132 · May 21, 2010
Related Publication 20250255872A1 · Aug 14, 2025
References Cited (400)
US 2985589A · Broughton et al. · 1961 [cited by applicant]
US 3832460A · Kosti · 1974 [cited by applicant]
US 4140755A · Sheth et al. · 1979 [cited by applicant]
US 4402832A · Gerhold · 1983 [cited by applicant]
US 4498991A · Oroskar · 1985 [cited by applicant]
US 4512984A · Seufert et al. · 1985 [cited by applicant]
US 4548990A · Mueller et al. · 1985 [cited by applicant]
US 4814477A · Wijnberg et al. · 1989 [cited by applicant]
US 5378700A · Sakuma et al. · 1995 [cited by applicant]
US 5472949A · Arasaki et al. · 1995 [cited by applicant]
US 5510101A · Stroppolo et al. · 1996 [cited by applicant]
US 5521184A · Zimmermann · 1996 [cited by applicant]
US 5630943A · Grill · 1997 [cited by applicant]
US 5702688A · Yu et al. · 1997 [cited by applicant]
US 5795909A · Shashoua et al. · 1998 [cited by applicant]
US 5856326A · Anthony et al. · 1999 [cited by applicant]
US 5919779A · Proudfoot et al. · 1999 [cited by applicant]
US 6025366A · Walsh et al. · 2000 [cited by applicant]
US 6060038A · Burns et al. · 2000 [cited by applicant]
US 6075056A · Quigley, Jr. et al. · 2000 [cited by applicant]
US 6136198A · Adam et al. · 2000 [cited by applicant]
US 6217895B1 · Guo et al. · 2001 [cited by applicant]
US 6335342B1 · Longo et al. · 2002 [cited by applicant]
US 6375839B1 · Adam et al. · 2002 [cited by applicant]
US 6413419B1 · Adam et al. · 2002 [cited by applicant]
US 6486322B1 · Longo et al. · 2002 [cited by applicant]
US 6518265B1 · Kato et al. · 2003 [cited by applicant]
US 6548078B2 · Guo et al. · 2003 [cited by applicant]
US 6569443B1 · Dawson et al. · 2003 [cited by applicant]
US 6579882B2 · Stewart et al. · 2003 [cited by applicant]
US 6624138B1 · Sung et al. · 2003 [cited by applicant]
US 6635762B1 · Blumenkopf et al. · 2003 [cited by applicant]
US 6712973B2 · Adam et al. · 2004 [cited by applicant]
US 6713089B1 · Bertelsen et al. · 2004 [cited by applicant]
US 6852727B2 · Goulet et al. · 2005 [cited by applicant]
US 6953776B2 · Di Napoli · 2005 [cited by applicant]
US 7005436B2 · Lloyd et al. · 2006 [cited by applicant]
US 7167750B2 · Knudson et al. · 2007 [cited by applicant]
US 7265108B2 · Ozaki et al. · 2007 [cited by applicant]
US 7335667B2 · Rodgers et al. · 2008 [cited by applicant]
US 7358255B2 · Nakamura et al. · 2008 [cited by applicant]
US 7517870B2 · Auricchio et al. · 2009 [cited by applicant]
US 7598257B2 · Rodgers et al. · 2009 [cited by applicant]
US 7683171B2 · Pitts et al. · 2010 [cited by applicant]
US 7745437B2 · Ren et al. · 2010 [cited by applicant]
US 7750007B2 · Bearss et al. · 2010 [cited by applicant]
US 7834022B2 · Rodgers et al. · 2010 [cited by applicant]
US 8053433B2 · Rodgers et al. · 2011 [cited by applicant]
US 8158616B2 · Rodgers et al. · 2012 [cited by applicant]
US 8309718B2 · Li et al. · 2012 [cited by applicant]
US 8410265B2 · Zhou et al. · 2013 [cited by applicant]
US 8415362B2 · Rodgers et al. · 2013 [cited by applicant]
US 8420629B2 · Rodgers et al. · 2013 [cited by applicant]
US 8440679B2 · Mc Allister et al. · 2013 [cited by applicant]
US 8445488B2 · Rodgers et al. · 2013 [cited by applicant]
US 8486902B2 · Rodgers et al. · 2013 [cited by applicant]
US 8513270B2 · Arvanitis et al. · 2013 [cited by applicant]
US 8530485B2 · Rodgers et al. · 2013 [cited by applicant]
US 8541425B2 · Rodgers et al. · 2013 [cited by applicant]
US 8563541B2 · Arvanitis et al. · 2013 [cited by applicant]
US 8604043B2 · Li et al. · 2013 [cited by applicant]
US 8637529B2 · Woller et al. · 2014 [cited by applicant]
US 8691807B2 · Yao et al. · 2014 [cited by applicant]
US 8715700B2 · Chang et al. · 2014 [cited by applicant]
US 8716303B2 · Rodgers et al. · 2014 [cited by applicant]
US 8722693B2 · Rodgers et al. · 2014 [cited by applicant]
US 8741895B2 · Rodgers et al. · 2014 [cited by applicant]
US 8748401B2 · Rodgers et al. · 2014 [cited by applicant]
US 8765734B2 · Huang et al. · 2014 [cited by applicant]
US 8822481B1 · Rodgers et al. · 2014 [cited by applicant]
US 8829013B1 · Rodgers et al. · 2014 [cited by applicant]
US 8835423B2 · Arvanitis et al. · 2014 [cited by applicant]
US 8841318B2 · Arvanitis et al. · 2014 [cited by applicant]
US 8883806B2 · Zhou · 2014 [cited by applicant]
US 8889697B2 · Rodgers et al. · 2014 [cited by applicant]
US 8933085B2 · Rodgers et al. · 2015 [cited by applicant]
US 8933086B2 · Rodgers et al. · 2015 [cited by applicant]
US 8946245B2 · Rodgers et al. · 2015 [cited by applicant]
US 8987442B2 · Tung et al. · 2015 [cited by applicant]
US 8987443B2 · Liu et al. · 2015 [cited by applicant]
US 8993582B2 · Zhou et al. · 2015 [cited by applicant]
US 9000161B2 · Zhou et al. · 2015 [cited by applicant]
US 9023840B2 · Yao et al. · 2015 [cited by applicant]
US 9034884B2 · Rodgers et al. · 2015 [cited by applicant]
US 9079912B2 · Rodgers et al. · 2015 [cited by applicant]
US 9090611B2 · Rodgers et al. · 2015 [cited by applicant]
US 9181271B2 · Li et al. · 2015 [cited by applicant]
US 9206187B2 · Rodgers et al. · 2015 [cited by applicant]
US 9216984B2 · Li et al. · 2015 [cited by applicant]
US 9221845B2 · Cao · 2015 [cited by applicant]
US 9290506B2 · Zhou et al. · 2016 [cited by applicant]
US 9334274B2 · Rodgers et al. · 2016 [cited by applicant]
US 9359358B2 · Rodgers et al. · 2016 [cited by applicant]
US 9376439B2 · Rodgers et al. · 2016 [cited by applicant]
US 9464088B2 · Huang et al. · 2016 [cited by applicant]
US 9487521B2 · Zhou et al. · 2016 [cited by applicant]
US 9498467B2 · Leopold et al. · 2016 [cited by applicant]
US 9611269B2 · Yao et al. · 2017 [cited by applicant]
US 9623029B2 · Li et al. · 2017 [cited by applicant]
US 9655854B2 · Yeleswaram et al. · 2017 [cited by applicant]
US 9974790B2 · Rodgers et al. · 2018 [cited by applicant]
US 9999619B2 · Huang et al. · 2018 [cited by applicant]
US 10398699B2 · Rodgers et al. · 2019 [cited by applicant]
US 20020111353A1 · Ledeboer et al. · 2002 [cited by applicant]
US 20030064969A1 · Bhagwat et al. · 2003 [cited by applicant]
US 20030100756A1 · Adams et al. · 2003 [cited by applicant]
US 20030144309A1 · Choon-Moon · 2003 [cited by applicant]
US 20030165576A1 · Fujii et al. · 2003 [cited by applicant]
US 20040009222A1 · Chou et al. · 2004 [cited by applicant]
US 20040009983A1 · Cox et al. · 2004 [cited by applicant]
US 20040029857A1 · Hale et al. · 2004 [cited by applicant]
US 20040077654A1 · Bouillot et al. · 2004 [cited by applicant]
US 20040099204A1 · Nestor · 2004 [cited by applicant]
US 20040198737A1 · Cox et al. · 2004 [cited by applicant]
US 20040204404A1 · Zelle et al. · 2004 [cited by applicant]
US 20040214928A1 · Aronov et al. · 2004 [cited by applicant]
US 20040235862A1 · Burns et al. · 2004 [cited by applicant]
US 20050014966A1 · Tabe et al. · 2005 [cited by applicant]
US 20050054568A1 · Ling et al. · 2005 [cited by applicant]
US 20050153989A1 · Grotzfeld et al. · 2005 [cited by applicant]
US 20060004010A1 · Habashita et al. · 2006 [cited by applicant]
US 20060020011A1 · Wu et al. · 2006 [cited by applicant]
US 20060079511A1 · Liu et al. · 2006 [cited by applicant]
US 20060106020A1 · Rodgers et al. · 2006 [cited by applicant]
US 20060106027A1 · Furet et al. · 2006 [cited by applicant]
US 20060128803A1 · Klimko et al. · 2006 [cited by applicant]
US 20060135537A1 · Knegtel et al. · 2006 [cited by applicant]
US 20060178393A1 · Pitts et al. · 2006 [cited by applicant]
US 20060183761A1 · Ledeboer et al. · 2006 [cited by applicant]
US 20060183906A1 · Rodgers et al. · 2006 [cited by applicant]
US 20060223864A1 · Biju et al. · 2006 [cited by applicant]
US 20060293311A1 · Li et al. · 2006 [cited by applicant]
US 20070135461A1 · Rodgers et al. · 2007 [cited by applicant]
US 20070135466A1 · Ledeboer et al. · 2007 [cited by applicant]
US 20070149506A1 · Arvanitis et al. · 2007 [cited by applicant]
US 20070149561A1 · Dhanak et al. · 2007 [cited by applicant]
US 20070191364A1 · Braun et al. · 2007 [cited by applicant]
US 20070191405A1 · Noronha et al. · 2007 [cited by applicant]
US 20070208053A1 · Arnold et al. · 2007 [cited by applicant]
US 20070225286A1 · Ren et al. · 2007 [cited by applicant]
US 20070259904A1 · Noronha et al. · 2007 [cited by applicant]
US 20070264344A1 · Segura-Orsoni et al. · 2007 [cited by applicant]
US 20080021026A1 · Kahraman et al. · 2008 [cited by applicant]
US 20080085898A1 · Lu et al. · 2008 [cited by applicant]
US 20080096852A1 · Yanni et al. · 2008 [cited by applicant]
US 20080119496A1 · Ohlmeyer et al. · 2008 [cited by applicant]
US 20080161346A1 · Cheng et al. · 2008 [cited by applicant]
US 20080188500A1 · Arvanitis et al. · 2008 [cited by applicant]
US 20080194468A1 · Bodor · 2008 [cited by applicant]
US 20080207570A1 · Segura-Orsoni · 2008 [cited by applicant]
US 20080207584A1 · Habashita et al. · 2008 [cited by applicant]
US 20080280876A1 · Hobson et al. · 2008 [cited by applicant]
US 20080312258A1 · Rodgers et al. · 2008 [cited by applicant]
US 20080312259A1 · Rodgers et al. · 2008 [cited by applicant]
US 20090018156A1 · Tang et al. · 2009 [cited by applicant]
US 20090076070A1 · Harada et al. · 2009 [cited by applicant]
US 20090088445A1 · Ledeboer et al. · 2009 [cited by applicant]
US 20090131403A1 · Kusuda et al. · 2009 [cited by applicant]
US 20090181959A1 · Rodgers et al. · 2009 [cited by applicant]
US 20090197869A1 · Arvanitis et al. · 2009 [cited by applicant]
US 20090203637A1 · Hocek et al. · 2009 [cited by applicant]
US 20090215766A1 · Rodgers et al. · 2009 [cited by applicant]
US 20090221608A1 · Cui et al. · 2009 [cited by applicant]
US 20090233903A1 · Rodgers et al. · 2009 [cited by applicant]
US 20090318405A1 · Li et al. · 2009 [cited by applicant]
US 20100022522A1 · Rodgers et al. · 2010 [cited by applicant]
US 20100069381A1 · Itoh · 2010 [cited by applicant]
US 20100113416A1 · Friedman et al. · 2010 [cited by applicant]
US 20100190981A1 · Zhou et al. · 2010 [cited by applicant]
US 20100210627A1 · Mao et al. · 2010 [cited by applicant]
US 20100298334A1 · Rodgers et al. · 2010 [cited by applicant]
US 20100298355A1 · Li et al. · 2010 [cited by applicant]
US 20110059951A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110082159A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110086810A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110086835A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110201593A1 · Babu et al. · 2011 [cited by applicant]
US 20110207754A1 · Li et al. · 2011 [cited by applicant]
US 20110223210A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110224157A1 · Rodgers et al. · 2011 [cited by applicant]
US 20110224190A1 · Huang et al. · 2011 [cited by applicant]
US 20110288107A1 · Parikh et al. · 2011 [cited by applicant]
US 20120014989A1 · Rodgers et al. · 2012 [cited by applicant]
US 20120077798A1 · Rodgers et al. · 2012 [cited by applicant]
US 20120149681A1 · Rodgers et al. · 2012 [cited by applicant]
US 20120149682A1 · Rodgers et al. · 2012 [cited by applicant]
US 20120214825A1 · Vannucchi et al. · 2012 [cited by applicant]
US 20120225057A1 · Flynn et al. · 2012 [cited by applicant]
US 20120252779A1 · Ramsden et al. · 2012 [cited by applicant]
US 20120301464A1 · Friedman et al. · 2012 [cited by applicant]
US 20120329782A1 · Arvanitis et al. · 2012 [cited by applicant]
US 20130018034A1 · Yao et al. · 2013 [cited by applicant]
US 20130040973A1 · Vannucchi et al. · 2013 [cited by applicant]
US 20130045963A1 · Rodgers et al. · 2013 [cited by applicant]
US 20130060026A1 · Zhou et al. · 2013 [cited by applicant]
US 20130137681A1 · Rodgers et al. · 2013 [cited by applicant]
US 20130225556A1 · Rodgers et al. · 2013 [cited by applicant]
US 20130253190A1 · Zhou · 2013 [cited by applicant]
US 20130253191A1 · Zhou · 2013 [cited by applicant]
US 20130253193A1 · Zhou · 2013 [cited by applicant]
US 20130274257A1 · Arvanitis et al. · 2013 [cited by applicant]
US 20130296299A1 · Rodgers et al. · 2013 [cited by applicant]
US 20140004516A1 · Sattler et al. · 2014 [cited by applicant]
US 20140005166A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140005210A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140018374A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140031344A1 · Arvanitis et al. · 2014 [cited by applicant]
US 20140073657A1 · Li et al. · 2014 [cited by applicant]
US 20140094477A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140121198A1 · Li et al. · 2014 [cited by applicant]
US 20140135350A1 · Ni et al. · 2014 [cited by applicant]
US 20140171409A1 · Yao et al. · 2014 [cited by applicant]
US 20140221379A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140228346A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140243360A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140256941A1 · Liu et al. · 2014 [cited by applicant]
US 20140275031A1 · Huang et al. · 2014 [cited by applicant]
US 20140303196A1 · Rodgers et al. · 2014 [cited by applicant]
US 20140343030A1 · Li et al. · 2014 [cited by applicant]
US 20140378400A1 · Rodgers et al. · 2014 [cited by applicant]
US 20150065447A1 · Sandor · 2015 [cited by applicant]
US 20150065484A1 · Yeleswaram et al. · 2015 [cited by applicant]
US 20150087632A1 · Rodgers et al. · 2015 [cited by applicant]
US 20150087662A1 · Li et al. · 2015 [cited by applicant]
US 20150152117A1 · Gibbons et al. · 2015 [cited by applicant]
US 20150164900A1 · Rodgers et al. · 2015 [cited by applicant]
US 20150183805A1 · Liu et al. · 2015 [cited by applicant]
US 20150225411A1 · Yao et al. · 2015 [cited by applicant]
US 20150225412A1 · Brameld et al. · 2015 [cited by applicant]
US 20150238492A1 · Rodgers et al. · 2015 [cited by applicant]
US 20150246046A1 · Vaddi · 2015 [cited by applicant]
US 20150250790A1 · Parikh et al. · 2015 [cited by applicant]
US 20150315185A1 · Rodgers et al. · 2015 [cited by applicant]
US 20150342952A1 · Leopold et al. · 2015 [cited by applicant]
US 20150344497A1 · Zhou et al. · 2015 [cited by applicant]
US 20160000795A1 · Scherle et al. · 2016 [cited by applicant]
US 20160015695A1 · Li et al. · 2016 [cited by applicant]
US 20160024109A1 · Li et al. · 2016 [cited by applicant]
US 20160067253A1 · Li et al. · 2016 [cited by applicant]
US 20160272648A1 · Rodgers et al. · 2016 [cited by applicant]
US 20160346286A1 · Rodgers et al. · 2016 [cited by applicant]
US 20160347734A1 · Liu et al. · 2016 [cited by applicant]
US 20170015674A1 · Zhou et al. · 2017 [cited by applicant]
US 20170071947A1 · Rodgers et al. · 2017 [cited by applicant]
US 20170087158A1 · Friedman et al. · 2017 [cited by applicant]
US 20170246157A1 · Huang et al. · 2017 [cited by applicant]
US 20170253598A1 · Yao et al. · 2017 [cited by applicant]
US 20170319487A1 · Yeleswaram et al. · 2017 [cited by applicant]
US 20180338978A1 · Rodgers et al. · 2018 [cited by applicant]
US 20180353499A1 · Huang et al. · 2018 [cited by applicant]
US 20190111058A1 · Vaddi · 2019 [cited by applicant]
US 20190125750A1 · Rodgers et al. · 2019 [cited by applicant]
US 20190135813A1 · Rodgers et al. · 2019 [cited by applicant]
CN 102026999B · 2014 [cited by applicant]
CN 102985417B · 2015 [cited by applicant]
CN 102458581B · 2016 [cited by applicant]
DE 3036390A1 · 1982 [cited by applicant]
EP 0223420B1 · 1991 [cited by applicant]
EP 0727217A2 · 1996 [cited by applicant]
EP 0795556A1 · 1997 [cited by applicant]
JP H0710876A · 1995 [cited by applicant]
JP 2003155285A · 2003 [cited by applicant]
JP 2004531513A · 2004 [cited by applicant]
JP 2006502183A · 2006 [cited by applicant]
JP 2006518341A · 2006 [cited by applicant]
JP 2008508241A · 2008 [cited by applicant]
JP 2008545660A · 2008 [cited by applicant]
JP 2009504619A · 2009 [cited by applicant]
JP 2010529209A · 2010 [cited by applicant]
JP 2011503194A · 2011 [cited by applicant]
JP 2011514909A · 2011 [cited by applicant]
JP 2013522214A · 2013 [cited by applicant]
JP 2013543007A · 2013 [cited by applicant]
MX 2015005428A · 2015 [cited by applicant]
MX 2015015738A · 2016 [cited by applicant]
WO 1996030343A1 · 1996 [cited by applicant]
WO 1997002262A1 · 1997 [cited by applicant]
WO 1997036587A1 · 1997 [cited by applicant]
WO 1997038664A2 · 1997 [cited by applicant]
WO 1997045412A1 · 1997 [cited by applicant]
WO 1998044797A1 · 1998 [cited by applicant]
WO 1998051391A1 · 1998 [cited by applicant]
WO 1999000654A2 · 1999 [cited by applicant]
WO 1999062908A2 · 1999 [cited by applicant]
WO 1999065909A1 · 1999 [cited by applicant]
WO 2000009495A1 · 2000 [cited by applicant]
WO 2000051614A1 · 2000 [cited by applicant]
WO 2000053595A1 · 2000 [cited by applicant]
WO 2000063168A1 · 2000 [cited by applicant]
WO 2001014402A1 · 2001 [cited by applicant]
WO 2001027104A1 · 2001 [cited by applicant]
WO 2001042246A2 · 2001 [cited by applicant]
WO 2001064655A1 · 2001 [cited by applicant]
WO 2001081345A1 · 2001 [cited by applicant]
WO 2001081346A2 · 2001 [cited by applicant]
WO 2001098344A2 · 2001 [cited by applicant]
WO 2002000196A2 · 2002 [cited by applicant]
WO 2002000661A1 · 2002 [cited by applicant]
WO 2002046184A1 · 2002 [cited by applicant]
WO 2002055084A1 · 2002 [cited by applicant]
WO 2002055496A1 · 2002 [cited by applicant]
WO 2002060492A1 · 2002 [cited by applicant]
WO 2002080926A1 · 2002 [cited by applicant]
WO 2002092573A2 · 2002 [cited by applicant]
WO 2002096909A1 · 2002 [cited by applicant]
WO 2003000688A1 · 2003 [cited by applicant]
WO 2003000695A1 · 2003 [cited by applicant]
WO 2003011285A1 · 2003 [cited by applicant]
WO 2003024967A2 · 2003 [cited by applicant]
WO 2003037347A1 · 2003 [cited by applicant]
WO 2003048162A1 · 2003 [cited by applicant]
WO 2003092595A2 · 2003 [cited by applicant]
WO 2003099771A2 · 2003 [cited by applicant]
WO 2003099796A1 · 2003 [cited by applicant]
WO 2004003026A1 · 2004 [cited by applicant]
WO 2004005281A1 · 2004 [cited by applicant]
WO 2004005282A1 · 2004 [cited by applicant]
WO 2004026406A1 · 2004 [cited by applicant]
WO 2004041814A1 · 2004 [cited by applicant]
WO 2004046120A2 · 2004 [cited by applicant]
WO 2004047843A1 · 2004 [cited by applicant]
WO 2004056786A2 · 2004 [cited by applicant]
WO 2004072063A1 · 2004 [cited by applicant]
WO 2004080980A1 · 2004 [cited by applicant]
WO 2004092154A1 · 2004 [cited by applicant]
WO 2004099204A1 · 2004 [cited by applicant]
WO 2004099205A1 · 2004 [cited by applicant]
WO 2005005988A2 · 2005 [cited by applicant]
WO 2005013986A1 · 2005 [cited by applicant]
WO 2005020921A2 · 2005 [cited by applicant]
WO 2005026129A1 · 2005 [cited by applicant]
WO 2005028444A1 · 2005 [cited by applicant]
WO 2005049033A1 · 2005 [cited by applicant]
WO 2005051393A1 · 2005 [cited by applicant]
WO 2005060972A2 · 2005 [cited by applicant]
WO 2005061463A1 · 2005 [cited by applicant]
WO 2005062795A2 · 2005 [cited by applicant]
WO 2005089502A2 · 2005 [cited by applicant]
WO 2005095400A1 · 2005 [cited by applicant]
WO 2005105146A1 · 2005 [cited by applicant]
WO 2005105814A1 · 2005 [cited by applicant]
WO 2005105988A2 · 2005 [cited by applicant]
WO 2005110410A2 · 2005 [cited by applicant]
WO 2005117909A2 · 2005 [cited by applicant]
WO 2005121130A2 · 2005 [cited by applicant]
WO 2005123719A1 · 2005 [cited by applicant]
WO 2006004984A1 · 2006 [cited by applicant]
WO 2006013114A1 · 2006 [cited by applicant]
WO 2006022459A1 · 2006 [cited by applicant]
WO 2006039718A2 · 2006 [cited by applicant]
WO 2006046023A1 · 2006 [cited by applicant]
WO 2006046024A1 · 2006 [cited by applicant]
WO 2006052913A1 · 2006 [cited by applicant]
WO 2006056399A2 · 2006 [cited by applicant]
WO 2006067445A2 · 2006 [cited by applicant]
WO 2006069080A2 · 2006 [cited by applicant]
WO 2006077499A1 · 2006 [cited by applicant]
WO 2006096270A1 · 2006 [cited by applicant]
WO 2006101783A2 · 2006 [cited by applicant]
WO 2006108103A1 · 2006 [cited by applicant]
WO 2006122806A2 · 2006 [cited by applicant]
WO 2006127587A1 · 2006 [cited by applicant]
WO 2006129199A1 · 2006 [cited by applicant]
WO 2006136823A1 · 2006 [cited by applicant]
WO 2007002433A1 · 2007 [cited by applicant]
WO 2007025090A2 · 2007 [cited by applicant]
WO 2007041130A2 · 2007 [cited by applicant]
WO 2007043677A1 · 2007 [cited by applicant]
WO 2007044050A2 · 2007 [cited by applicant]
WO 2007044894A2 · 2007 [cited by applicant]
WO 2007049041A1 · 2007 [cited by applicant]
WO 2007062459A1 · 2007 [cited by applicant]
WO 2007070514A1 · 2007 [cited by applicant]
WO 2007076423A2 · 2007 [cited by applicant]
WO 2007077949A1 · 2007 [cited by applicant]
WO 2007084557A2 · 2007 [cited by applicant]
WO 2007090141A2 · 2007 [cited by applicant]
WO 2007090748A1 · 2007 [cited by applicant]
WO 2007116313A2 · 2007 [cited by applicant]
WO 2007117494A1 · 2007 [cited by applicant]
WO 2007129195A2 · 2007 [cited by applicant]
WO 2007135461A2 · 2007 [cited by applicant]
WO 2007140222A2 · 2007 [cited by applicant]
WO 2008013925A2 · 2008 [cited by applicant]
WO 2008028937A1 · 2008 [cited by applicant]
WO 2008035376A2 · 2008 [cited by applicant]
WO 2008043031A1 · 2008 [cited by applicant]
WO 2008058126A2 · 2008 [cited by applicant]
WO 2008064157A1 · 2008 [cited by applicant]
WO 2008067119A2 · 2008 [cited by applicant]
WO 2008077712A1 · 2008 [cited by applicant]
WO 2008079291A2 · 2008 [cited by applicant]
WO 2008079292A1 · 2008 [cited by applicant]
WO 2008082198A1 · 2008 [cited by applicant]
WO 2008082839A2 · 2008 [cited by applicant]
WO 2008082840A1 · 2008 [cited by applicant]
WO 2008106692A1 · 2008 [cited by applicant]
WO 2008124323A1 · 2008 [cited by applicant]
WO 2008139161A1 · 2008 [cited by applicant]
WO 2008145681A2 · 2008 [cited by applicant]